发明名称 |
Sales de 5-[(1r)-2-([2-[4-(2,2-difluoro-2-feniletoxi)fenil]etil]amino)-1-hidroxietil]-8-hidroxiquinolin-2(1h)-ona; composicion y combinacion farmaceutica que las comprende y uso en el tratamiento del asma o epoc. |
摘要 |
<p>The present invention is directed to a pharmaceutically acceptable crystalline addition salt of (i) 5-[(1R)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl]ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1H)-one, and (ii) a dicarboxylic acid, a sulfonic acid or a sulfimide, or a pharmaceutically acceptable solvate thereof.</p> |
申请公布号 |
CL2014002558(A1) |
申请公布日期 |
2014.11.28 |
申请号 |
CL20140002558 |
申请日期 |
2014.09.25 |
申请人 |
ALMIRALL S.A. |
发明人 |
PUIG DURAN CARLOS;CARRERA CARRERA FRANCESC;PEREZ GARCIA JUAN BAUTISTA;MOYES VALLS ENRIQUE;MARCHUETA HEREU IOLANDA |
分类号 |
C07D215/22;A61K31/4704;A61P11/00 |
主分类号 |
C07D215/22 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|